Rep. Hon. Julia Letlow discloses trade(s) in MMM, ABT, ABBV, ACN, ADBE
Julia Letlow (LA05) disclosed 12 transactions, traded Oct 23 – Dec 8: 7 purchases and 5 sales.
| Traded | Ticker | Company | Action | Amount | Owner |
|---|---|---|---|---|---|
| Dec 8 | ABT | Abbott Laboratories | Sell | $1,001 - $15,000 | Self |
| Dec 8 | ABBV | AbbVie Inc. | Sell | $1,001 - $15,000 | Self |
| Jul 24 | ACN | Accenture plc | Sell | $1,001 - $15,000 | Self |
| Apr 28 | ABBV | AbbVie Inc. | Buy | $1,001 - $15,000 | Self |
| Apr 22 | ACN | Accenture plc | Buy | $1,001 - $15,000 | Self |
| Jan 24 | ABBV | AbbVie Inc. | Sell | $1,001 - $15,000 | Self |
| Jan 24 | ADBE | Adobe Inc. | Buy | $1,001 - $15,000 | Self |
| Jan 17 | MMM | 3M Company | Buy | $1,001 - $15,000 | Self |
| Jan 15 | ACN | Accenture plc | Sell | $1,001 - $15,000 | Self |
| Oct 23 | ABT | Abbott Laboratories | Buy | $1,001 - $15,000 | Self |
| Oct 23 | ABBV | AbbVie Inc. | Buy | $1,001 - $15,000 | Self |
| Oct 23 | ACN | Accenture plc | Buy | $1,001 - $15,000 | Self |
ORIGINAL FILING ↗ALL FILINGS BY JULIA LETLOW →CONGRESS TRADES DASHBOARD →
Amounts are the ranges members report. Rows are read automatically from the filing; a trade split across a page break can be missed, so the original filing is the full record.
What This Means
A U.S. representative has filed a financial disclosure covering equity transactions in five large-cap stocks spanning industrial, healthcare, software, and consulting sectors. Congressional stock trading disclosures are public records that can signal insider positioning or simply reflect routine portfolio management. Such filings are tracked by market observers and governance-focused investors as part of broader monitoring of legislative trading activity.
Sources — 1 tier
Every claim below links directly to the original reporting it was drawn from. Penblock synthesizes and cross-references these sources — it doesn't originate the reporting.
- Hon. Julia LetlowSep 30, 2026Rep. Hon. Julia Letlow discloses trade(s) in MMM, ABT, ABBV, ACN, ADBE ↗
How This Could Play Out — recorded when first flagged, not updated
Resolve
UNLIKELYA formal ethics investigation or legislative action addressing congressional trading practices could create temporary uncertainty in large-cap stocks held by multiple lawmakers, though the impact would likely be diffuse across the broad market rather than concentrated.
Left Unattended
LIKELYThe disclosure remains a routine filing with no follow-up scrutiny or regulatory action, leaving market participants to treat it as ordinary portfolio rebalancing with no material implications for the underlying securities.
Escalate
POSSIBLEIf the timing or pattern of these trades triggers media attention or congressional inquiry into potential conflicts of interest or non-public information use, it could amplify existing concerns about legislative trading practices and create headwinds for sentiment around governance-sensitive institutional investors.
SPONSORED
Confidence History
- HIGH CONFIDENCESep 30, 2026 at 12:02 AM
Legally mandated financial disclosure filing -- primary source, not a report about the event